62
Research Trials
22
Peer-reviewed publications
17
Clinical Conditions

Updated interim data from 54 COPD patients and 135,000 monitored hours, showing cough rates rise in the days before exacerbations and correlate only weakly with CAT scores.

A month of continuous monitoring in stable chronic cough shows that multi-day averaging makes cough frequency a more reliable trial endpoint, allowing smaller studies, and reveals a short-lived Hawthorne effect.

Mixed-methods study in Kampala assessing 48-hour cough frequency monitoring with the Hyfe Research app for TB screening and triage, alongside staff-reported implementation barriers.
18 June 2026

Understanding the natural variability of cough frequency is essential for designing antitussive trials. This prospective observational study used Hyfe continuous cough monitoring to characterize daily cough variability and its relationship with patient-reported outcomes in clinically stable patients with refractory or unexplained chronic cough.
Across 928 person-days and over 300,000 recorded coughs, average hourly cough rates ranged from 2.1 to 51.2, with substantial day-to-day variability within individuals. Daily VAS scores correlated poorly with objective cough counts (r = 0.23). Among participants rating their cough below 40 on the VAS, 28% coughed more than 10 times per hour. The authors conclude that VAS-based screening thresholds alone may exclude patients with objectively high cough rates. The work was also presented at the ERS Cough Conference 2026 in London.